304 related articles for article (PubMed ID: 36832332)
1. Nutritional Aspects of Juvenile Idiopathic Arthritis: An A to Z for Dietitians.
Grammatikopoulou MG; Gkiouras K; Syrmou V; Vassilakou T; Simopoulou T; Katsiari CG; Goulis DG; Bogdanos DP
Children (Basel); 2023 Jan; 10(2):. PubMed ID: 36832332
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the relationship between nutritional status, dietary intake, symptoms and health-related quality of life in children and young people with juvenile idiopathic arthritis: a systematic review and meta-analysis.
Zare N; Mansoubi M; Coe S; Najafi AA; Bailey K; Harrison K; Sheehan J; Dawes H; Barker K
BMC Pediatr; 2023 Jan; 23(1):3. PubMed ID: 36593466
[TBL] [Abstract][Full Text] [Related]
3. An Overview of Nutritional Aspects in Juvenile Idiopathic Arthritis.
Zandonadi RP
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297096
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
6. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
McMahan R; Balfe LM; Greene L
J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
[TBL] [Abstract][Full Text] [Related]
7. Body composition and phase angle as an indicator of nutritional status in children with juvenile idiopathic arthritis.
Więch P; Sałacińska I; Bazaliński D; Dąbrowski M
Pediatr Rheumatol Online J; 2018 Dec; 16(1):82. PubMed ID: 30587206
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Status Among Children With Juvenile Idiopathic Arthritis: A Multicenter Prospective, Non-randomized, Comparative Study.
Kondratyeva EI; Odinaeva ND; Klimov LY; Podchernyaeva NS; Ilenkova NI; Dolbnya SV; Zhekaite EK; Kuryaninova VA; Kotova YV; Tikhaya MI; Shitkovskaya EP; Bychina LV; Drepa TG; Zodbinova AE; Melyanovskaya YL; Petrova NV; Loshkova EV; Kutsev SI
Front Pediatr; 2022; 10():915943. PubMed ID: 35967569
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study.
Huemer M; Födinger M; Huemer C; Sailer-Höck M; Falger J; Rettenbacher A; Bernecker M; Artacker G; Kenzian H; Lang T; Stöckler-Ipsiroglu S
Clin Exp Rheumatol; 2003; 21(2):249-55. PubMed ID: 12747286
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.
Thornton J; Ashcroft D; O'Neill T; Elliott R; Adams J; Roberts C; Rooney M; Symmons D
Health Technol Assess; 2008 Mar; 12(3):iii-ix, xi-xiv, 1-208. PubMed ID: 18284894
[TBL] [Abstract][Full Text] [Related]
11. Determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis.
Stagi S; Bertini F; Cavalli L; Matucci-Cerinic M; Brandi ML; Falcini F
J Rheumatol; 2014 Sep; 41(9):1884-92. PubMed ID: 25086083
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis.
Gicchino MF; Di Sessa A; Guarino S; Miraglia Del Giudice E; Olivieri AN; Marzuillo P
Eur J Pediatr; 2021 Feb; 180(2):655-661. PubMed ID: 32860100
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
Trials; 2014 Jan; 15():14. PubMed ID: 24405833
[TBL] [Abstract][Full Text] [Related]
14. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.
Raab A; Kallinich T; Huscher D; Foeldvari I; Weller-Heinemann F; Dressler F; Kuemmerle-Deschner JB; Klein A; Horneff G
Pediatr Rheumatol Online J; 2021 Mar; 19(1):41. PubMed ID: 33752685
[TBL] [Abstract][Full Text] [Related]
15. Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis.
Marini F; Falcini F; Stagi S; Fabbri S; Ciuffi S; Rigante D; Cerinic MM; Brandi ML
Sci Rep; 2020 Oct; 10(1):17550. PubMed ID: 33067526
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
[TBL] [Abstract][Full Text] [Related]
17. Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD.
Bardan I; Fagerli KM; Sexton J; Kvien TK; Bakland G; Mielnik P; Hu Y; Lien G; Flatø B; Molberg Ø; Kristianslund EK; Aga AB
J Rheumatol; 2023 Apr; 50(4):538-547. PubMed ID: 36379571
[TBL] [Abstract][Full Text] [Related]
18. [Low bone mineral density in juvenile idiopathic arthritis: Prevalence and related factors].
Galindo Zavala R; Núñez Cuadros E; Martín Pedraz L; Díaz-Cordovés Rego G; Sierra Salinas C; Urda Cardona A
An Pediatr (Barc); 2017 Oct; 87(4):218-225. PubMed ID: 28237653
[TBL] [Abstract][Full Text] [Related]
19. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate for treating juvenile idiopathic arthritis.
Takken T; Van Der Net J; Helders PJ
Cochrane Database Syst Rev; 2001; (4):CD003129. PubMed ID: 11687174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
